TotalPlex gene amplification using bulging primers for pharmacogenetic analysis of acute lymphoblastic leukemia

Molecular and Cellular Probes

Volumn 22, Issue 3, 2008, Pages 193-200

  Kang, Hyoung Jin ^a   Oh, Yongtaek ^b   Chun, Sung Min ^b   Seo, Young Jin ^a   Shin, Hee Young ^a   Kim, Chul Woo ^a   Ahn, Hyo Seop ^a   Han, Byoung Don ^b  

^a Seoul National University College of Medicine   (South Korea)

^b YeBT Co LTD   (South Korea)

Author keywords

Acute lymphoblastic leukemia; Bulging primer; Pharmacogenetics; TotalPlex

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTILEUKEMIC AGENT; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; GENOMIC DNA; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN; PROTEIN NR3C1; REDUCED FOLATE CARRIER; THIOPURINE METHYLTRANSFERASE; VITAMIN D RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; DNA DETERMINATION; EXON; GENE AMPLIFICATION; GENE DELETION; GENE LOCUS; GENOTYPE; HUMAN; INTRON; MICROARRAY ANALYSIS; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM;

DNA PRIMERS; GENOTYPE; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 43049102346     PISSN: 08908508     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcp.2008.02.001     Document Type: Article

References (22)

1. Rocha J.C., Cheng C., Liu W., Kishi S., Das S., Cook E.H., et al. Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood 105 (2005) 4752-4758
2. Fujimuro M., Nakaso K., Nakashima K., Sadanari H., Hisanori I., Teishikata Y., et al. Multiplex PCR-based DNA array for simultaneous detection of three human herpesviruses, EVB, CMV and KSHV. Exp Mol Pathol 80 (2006) 124-131
3. Wilson W.J., Erler A.M., Nasarabadi S.L., Skowronski E.W., and Imbro P.M. A multiplexed PCR-coupled liquid bead array for the simultaneous detection of four biothreat agents. Mol Cell Probes 19 (2005) 137-144
4. Lee S.H., Yeon S.W., Kang B.H., and Kim T.Y. Rapid identification of potentially probiotic Bifidobacterium species by multiplex PCR using species-specific primers based on the region extending from 16S rRNA through 23S rRNA. FEMS Microbiol Lett 250 (2005) 55-62
5. Hunt D.E., Klepac-Ceraj V., Acinas S.G., Gautier C., Bertilsson S., and Polz M.F. Evaluation of 23S rRNA PCR primers for use in phylogenetic studies of bacterial diversity. Appl Environ Microbiol 72 (2006) 2221-2225
6. Oh Y., Bae S.M., Kim Y.W., Choi H.S., Nam G.H., Han S.J., et al. Polymerase chain reaction-based fluorescent Luminex assay to detect the presence of human papillomavirus types. Cancer Sci 98 (2007) 549-554
7. Polz M.F., and Cavanaugh C.M. Bias in template-to-product ratios in multitemplate PCR. Appl Environ Microbiol 64 (1998) 3724-3730
8. Chen C.L., Liu Q., Pui C.H., Rivera G.K., Sandlund J.T., Ribeiro R., et al. Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemia. Blood 89 (1997) 1701-1707
9. Harris S.S., Eccleshall T.R., Gross C., Dawson-Hughes B., and Feldman D. The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women. J Bone Miner Res 12 (1997) 1043-1048
10. Kuehl P., Zhang J., Lin Y., Lamba J., Assem M., Schuetz J., et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 27 (2001) 383-391
11. Yates C.R., Krynetski E.Y., Loennechen T., Fessing M.Y., Tai H.L., Pui C.H., et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 126 8 (1997) 608-614
12. Kishi S., Griener J., Cheng C., Das S., Cook E.H., Pei D., et al. Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia. J Clin Oncol 21 (2003) 3084-3091
13. Van der Put N.M., Gabreels F., Stevens E.M., Smeitink J.A., Trijbels F.J., Eskes T.K., et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet 62 (1998) 1044-1051
14. Kishi S., Yang W., Boureau B., Morand S., Das S., Chen P., et al. Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia. Blood 103 (2004) 67-72
15. Roden D.M., Altman R.B., Benowitz N.L., Flockhart D.A., Giacomini K.M., Johnson J.A., et al., Pharmacogenetics Research Network. Pharmacogenomics: challenges and opportunities. Ann Intern Med 145 (2006) 749-757
16. Chun S.M., Kim Y.L., Choi H.B., Oh Y.T., Kim Y.J., Lee S., et al. Identification of leukemia-specific fusion gene transcripts with a novel oligonucleotide array. Mol Diagn Ther 11 (2007) 21-28
17. Kishi S., Cheng C., French D., Pei D., Das S., Cook E.H., et al. Ancestry and pharmacogenetics of antileukemic drug toxicity. Blood 109 (2007) 4151-4157
18. de Leon J., Susce M.T., and Murray-Carmichael E. The AmpliChip CYP450 genotyping test: integrating a new clinical tool. Mol Diagn Ther 10 (2006) 135-151
19. Couzin J. Pharmacogenomics. Cancer sharpshooters rely on DNA tests for a better aim. Science 305 (2004) 1222-1223
20. Zhu Y., Hein D.W., Doll M.A., Reynolds K.K., Abudu N., Valdes Jr. R., et al. Simultaneous determination of 7 N-acetyltransferase-2 single-nucleotide variations by allele-specific primer extension assay. Clin Chem 52 (2006) 1033-1039
21. Ye F., Li M.S., Taylor J.D., Nguyen Q., Colton H.M., Casey W.M., et al. Fluorescent microsphere-based readout technology for multiplexed human single nucleotide polymorphism analysis and bacterial identification. Hum Mutat 17 (2001) 305-316
22. Harries L.W., Stubbins M.J., Forman D., Howard G.C., and Wolf C.R. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18 (1997) 641-644